InvestorsHub Logo
Followers 78
Posts 2691
Boards Moderated 1
Alias Born 12/04/2020

Re: Catpole post# 138560

Saturday, 01/08/2022 9:55:02 PM

Saturday, January 08, 2022 9:55:02 PM

Post# of 200200
I would have preferred that they get one of their prescription medications out first, because there is a stigma with supplements and nutraceuticals. People tend to think of these companies as a joke. But we all know what ENZC has in Clone 3 and ITV-1, so regarding their over-the-counter IPF product: I say revenue is revenue. There is a large class of OTC investors who are ignorant to how small-cap biotech companies operate. They apply the old-school principles of sales/profit and solid quarterly reporting, when in reality it's all about the intellectual property and the potential of their bio technology. So some revenue in the upcoming year will quiet these morons up.

I hope we can bust through that 0.15s resistance in the coming week. I don't think we can consolidate in the 0.14-0.16 range unless we bust through the 0.15s and trade at 0.15 or above for at least a week. The MMs and the shorts/day traders still have a hold of this one. This stock would easily be trading steadily in the 0.35-0.50 range if not for those clowns. Every time we have a run, they beat us down with a 100% retracement, or more. Makes me furious.

JACK'S RULES OF TRADING
1. Never chase a stock that's already run up considerably.
2. Never panic sell. In other words: When in doubt, hold.
3. When the stock price is down but the company still has potential, add.